Efficacy of Botulinum Toxin A in Preventing Keloids, Randomized Control Trial Study : Intraindividual subject
Phase 3
- Conditions
- Wound outcome
- Registration Number
- TCTR20150811002
- Lead Sponsor
- no
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
The inclusion criteria were
1) over 18 years old,
2) having at least 2 sites or one site > 10 cm in length of hypertrophic scars or keloids
3) having unsightly scars that required scar revision or excision, and
4) volunteering to enroll in the study protocol.
Exclusion Criteria
The exclusion criteria were
1) allergic to botulinum toxin or xylocaine
2) pregnancy
3) breast feeding
4) received a previous injection of botulinum toxin within 6 months,
5) undesirable medical conditions
6) Taking anticoagulant or antiplatelet
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method vancouver scar scale 6 month Pair T test
- Secondary Outcome Measures
Name Time Method o No No